Attorney Santana McMurrey
Santana McMurrey is an accomplished attorney who joined the team at Arnold
& Itkin LLP in 2014. She focuses primarily on pharmaceutical injury
cases—particularly those involving children who have been injured
by dangerous prescription medications—as well as cases involving
serious offshore accidents, plant accidents, and more.
Raised in Freeport, Texas, Santana graduated from Brazosport High School
before going on to earn her bachelor's degree from the University
of Texas at Austin. She worked at a law firm in Houston after graduation,
which is where she decided to pursue a career in law.
While earning the Dean's Merit Scholarship and making the Dean's
List repeatedly at South Texas College of Law, Santana also worked part-time
as a law clerk. The valuable experience she gained from working on cases
in jurisdictions nationwide allowed her the perspective necessary to choose
an area of focused. She established a special interest in products and
premises liability cases—a niche that allows her to help families
all around the country.
Santana brings passion and excellence to her work as an attorney for Arnold
& Itkin LLP. She and her husband Marshall live in Houston with their
two dogs, Neil and Clark "Kent."
$76.6 Million Awarded to Boy Who Grew Female Breasts from Risperdal
Arnold & Itkin obtained the largest single verdict in a Risperdal-Gynecomastia case—$76.6 million. We are honored to have helped our client recover this amount!
A young boy who had developed female breasts as a result of taking Risperdal—a
drug manufactured by Johnson & Johnson and Janssen Pharmaceuticals—was
awarded a $76.6 million jury verdict. Represented by Attorneys Jason Itkin
and Kyle Findley of Arnold & Itkin, with help from Santana McMurrey
and Cory Itkin, the client was able to successfully hold Johnson &
Johnson and Janssen Pharmaceuticals accountable for their failure to disclose
the drug’s harmful side effects.
Once the boy’s family sued Johnson & Johnson for his symptoms
related to Risperdal—an anti-psychotic medication—Johnson
& Johnson maintained that the boy remained on the drug after knowing
about the side effects, that this drug was the only one that worked, and
that the drug did not have any ties to gynecomastia in young males. Through
cross-examination, evidence that became known as “Tab 4,”
showed that there was scientific data evidencing a link between Risperdal
and gynecomastia. Furthermore, it was evidenced that Johnson & Johnson
kept this information secret from scientific published studies, the FDA,
At the end of the 11-day trial, the jury awarded Arnold & Itkin’s
client $76.6 million after unanimously finding Johnson & Johnson and
Janssen Pharmaceuticals to be guilty of failing to warn consumers against
the dangerous side effects of the drug. This verdict is the largest single
verdict in a Risperdal-Gynecomastia case.
* Client’s portion of total recovery may be subject to Medicare / Medicaid reimbursement claims, Medicare / Medicaid liens or other third-party claims or liens. These verdicts and settlements are intended to be representative of cases handled by Arnold & Itkin LLP. These listings are not a guarantee or prediction of the outcome of any other claims.